iShares Biotechnology ETF
431 hedge funds and large institutions have $6B invested in iShares Biotechnology ETF in 2015 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 130 increasing their positions, 152 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 152
42% less call options, than puts
Call options by funds: $795M | Put options by funds: $1.37B
Holders
431
Holding in Top 10
32
Calls
$795M
Puts
$1.37B
Top Buyers
| 1 | +$398M | |
| 2 | +$82.1M | |
| 3 | +$64.2M | |
| 4 |
D.E. Shaw & Co
New York
|
+$19.4M |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$16.9M |
Top Sellers
| 1 | -$369M | |
| 2 | -$260M | |
| 3 | -$232M | |
| 4 |
Goldman Sachs
New York
|
-$162M |
| 5 |
JPMorgan Chase & Co
New York
|
-$131M |